Appendix C
Agendas: Open Committee Meetings
This appendix presents the agendas for the open portions of the committee’s meetings, at which a wide range of experts provided invaluable input to the committee’s deliberations.
Committee on Addressing Issues of Vaccine Distribution and Supply
Chains to Advance Pandemic and Seasonal Influenza Preparedness and Response
March Meeting
March 11, 2021: 12:00 pm ET – 1:30 pm ET
March 12, 2021: 11:00 am ET – 12:30 pm ET
March 17, 2021: 10:45 am – 1:15 pm ET
March 19, 2021: 11:00 am – 12:15 pm ET
Location: Virtual
Wednesday, March 17, 2021
OPEN SESSION
SESSION II |
SPONSOR BRIEFING: DISCUSSION OF THE COMMITTEE’S CHARGE |
10:45 a.m. | Welcome and Introductions |
RAVI ANUPINDI, Committee Chair |
|
Colonel William G. and Ann C. Svetlich Professor of Operations Research and |
|
Management Chair |
|
President’s Advisory Committee on Labor |
|
Standards and Human Rights |
|
University of Michigan |
|
10:55 a.m. |
Sponsor Perspective on Charge to the Committee |
LAWRENCE KERR, Sponsor |
|
Office of Pandemic and Emerging Threats |
|
Office of Global Affairs |
|
U.S. Department of Health and Human Services |
|
11:10 a.m. |
Q&A Discussion with Committee |
11:25 a.m. | BREAK |
SESSION III |
PANDEMIC INFLUENZA AND NEW PATHOGEN VACCINE DISTRIBUTION |
11:35 a.m. |
Needs in Influenza and New Pathogen Vaccine Distribution |
LISA HEDMAN |
|
Group Lead, Supply and Access to Medicines |
|
World Health Organization |
|
NAGWA HASANIN |
|
Senior Advisor, Health |
|
UNICEF |
|
STACEY KNOBLER |
|
Director, Influenza Vaccine Innovation |
|
Sabin Vaccine Institute |
Session Moderator |
|
PINAR KESKINOCAK |
|
William W. George Professor and Chair |
|
School of Industrial and Systems Engineering |
|
Georgia Institute of Technology |
|
1:00 p.m. |
Q&A Discussion with Committee |
1:15 p.m. | ADJOURN |
Friday, March 19, 2021
OPEN SESSION
SESSION IV |
NEEDS IN INFLUENZA VACCINE MANUFACTURING PREPAREDNESS |
11:00 a.m. |
Welcome and Recap of Day 1 |
11:10 a.m. | Needs in Influenza Vaccine Manufacturing Preparedness |
RICK BRIGHT | |
Senior Vice-President, Pandemic Preparedness |
|
The Rockefeller Foundation |
|
MATTHEW DOWNHAM | |
Sustainable Manufacturing Lead |
|
Coalition for Epidemic Preparedness Innovations (CEPI) |
|
TIAGO ROCCA | |
Strategic Partnerships and Business Development Manager |
|
Butantan Institute |
|
Session Moderator |
|
JENNIFER PANCORBO | |
Director, Industry Programs and Research |
|
North Carolina State University |
|
Biomanufacturing Training and Education Center |
|
11:55 a.m. | Q&A Discussion with Committee |
12:15 p.m. | ADJOURN OPEN SESSION |
April Meeting
April 23, 2021: 9:30 am ET – 12:00 pm ET
April 27, 2021: 11:30 am ET – 12:30 pm ET
April 30, 2021: Closed Session for Committee Members Only
Location: Virtual
Friday, April 23, 2021
OPEN SESSION
9:30 a.m. | Welcome |
RAVI ANUPINDI, Committee Chair |
|
Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management Chair |
|
President’s Advisory Committee on Labor Standards and Human Rights |
|
University of Michigan |
SESSION I CRITICAL INPUTS FOR VACCINE MANUFACTURING
Speakers will share their perspective on the critical inputs necessary for vaccine manufacturing.
9:35 a.m. | ROBERT JOHNSON |
Director, Influenza and Emerging Infectious Diseases Division |
|
Biomedical Advanced Research and Development Authority |
MICHAEL ANGELASTRO | |
Lead Interdisciplinary Scientist |
|
Biomedical Advanced Research and Development Authority |
|
9:50 a.m. |
Q&A Discussion with Committee |
10:05 a.m. | SAI PRASAD |
President of Quality Operations, Bharat |
|
Biotech International Ltd. |
|
10:20 a.m. |
Q&A Discussion with Committee |
10:35 a.m. | WILLIAM JAY TREAT |
Chief Manufacturing Officer and Principal Investigator |
|
Center for Innovation in Advanced Development & Manufacturing Texas A&M University |
|
10:50 a.m. | Q&A Discussion with Committee Moderator |
MATTHEW DOWNHAM | |
Sustainable Manufacturing Lead |
|
Coalition for Epidemic Preparedness Innovations |
|
11:05 a.m. | BREAK |
SESSION II NOVEL TECHNOLOGIES FOR INFLUENZA VACCINE MANUFACTURING
Speakers will discuss how novel technologies and advances in translational research and science, derived from the ongoing COVID-19 pandemic, have the potential to be adapted to scale-up and sustain influenza vaccine manufacturing capacities.
11:10 a.m. | Technology Scale-Up and Adaptability |
LYN MORGAN | |
Senior Director Global Public Affairs, Vaccines |
|
Sanofi Pasteur |
|
SURESH JADHAV | |
Executive Director |
|
Serum Institute of India |
PATRICK TIPPOO | |
Head of Science and Innovation |
|
Biovac Institute |
|
Moderator | |
RICK BRIGHT | |
Senior Vice-President, Pandemic Preparedness |
|
The Rockefeller Foundation |
|
11:40 a.m. | Q&A Discussion with Committee |
12:00 p.m. | ADJOURN |
Tuesday, April 27, 2021
OPEN SESSION
11:30 a.m. | Welcome and Recap of Day 1 |
RAVI ANUPINDI, Committee Chair | |
Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management |
|
Chair, President’s Advisory Committee on Labor Standards and Human Rights |
|
University of Michigan |
|
11:35 a.m. | Key Considerations for Vaccine Distribution |
PINAR KESKINOCAK | |
William W. George Professor and Chair |
|
School of Industrial and Systems Engineering |
|
Georgia Institute of Technology |
|
11:50 a.m. | Q&A Discussion with Committee |
12:00 p.m. | Vaccine Information Systems: Improvements Needed to Support Influenza |
SKYE GILBERT | |
Executive Director, Digital Square |
|
PATH |
12:15 p.m. | Q&A Discussion with Committee Moderator |
PRASHANT YADAV, Committee Vice Chair | |
Senior Fellow, Center for Global Development |
|
Professor, INSEAD |
|
Lecturer, Harvard Medical School |
|
12:30 p.m. | ADJOURN OPEN SESSION |
May Meeting
May 21, 2021: 11:25 am ET – 1:30 pm ET
Location: Virtual
Friday, May 21, 2021
OPEN SESSION
11:25 a.m. | Welcome & Recap of Day 2 |
RAVI ANUPINDI, Committee Chair | |
Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management Chair |
|
President’s Advisory Committee on Labor Standards and Human Rights |
|
University of Michigan |
|
11:30 a.m. | Cross-Border Processes and Approval for Vaccines and Vaccine Supplies |
ROY SANTANA | |
Counsellor |
|
Market Access Division |
|
World Trade Organization |
MICHAEL ROBERTS | |
Head, Aid for Trade Unit |
|
Development Division |
|
World Trade Organization |
|
ROGER KAMPF | |
Counsellor |
|
Intellectual Property Division |
|
World Trade Organization |
|
11:45 a.m. | Q&A Discussion with Committee |
Moderator | |
MATTHEW DOWNHAM | |
Sustainable Manufacturing Lead |
|
Coalition for Epidemic Preparedness Innovations |
|
12:00 p.m. | Pandemic Influenza Vaccine Distribution: The PIVI Model |
JOSEPH BRESEE | |
Associate Director of Global Health Affairs, Influenza Division |
|
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention |
|
Director, Partnership for Influenza Vaccine Introduction Task Force for Global Health |
|
Director, Global Funders Consortium for Universal Influenza Vaccine Development |
|
12:15 p.m. | Q&A Discussion with Committee Moderator |
RAVI ANUPINDI, Committee Chair | |
Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management |
|
Chair, President’s Advisory Committee on Labor Standards and Human Rights |
|
University of Michigan |
12:30 p.m. | WHO Training Programs and mRNA Hubs |
MARTIN FRIEDE | |
Coordinator |
|
Initiative for Vaccine Research |
|
World Health Organization |
|
12:45 p.m. | Q&A Discussion with Committee Moderator |
JENNIFER PANCORBO | |
Director, Industry Programs and Research |
|
Biomanufacturing Training and Education Center |
|
North Carolina State University |
|
1:00 p.m. | Navigating Vaccine Logistics in Africa |
AHMED OGWELL OUMA | |
Deputy Director |
|
Africa Centres for Disease Control and Prevention |
|
1:15 p.m. | Q&A Discussion with Committee Moderator |
RAVI ANUPINDI, Committee Chair | |
Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management |
|
Chair, President’s Advisory Committee on Labor Standards and Human Rights |
|
University of Michigan |
|
1:30 p.m. | ADJOURN OPEN SESSION |
This page intentionally left blank.